SCHEMBL14723511

SCHEMBL14723511

COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(=O)(=O)CI)CC2)nc1N

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 19/20 0.85
CDK4 P11802 18/20 0.85
CCND1 P24385 18/20 0.85
CDK2 P24941 18/20 0.85
CASK O14936 1/20 0.85
ROCK2 O75116 1/20 0.85
CDKL5 O76039 1/20 0.85
STK10 O94804 1/20 0.85
CDK14 O94921 1/20 0.85
ABL1 P00519 1/20 0.85
EGFR P00533 1/20 0.85
MAK P20794 1/20 0.85
CDK11B P21127 1/20 0.85
TTK P33981 1/20 0.85
CLK1 P49759 1/20 0.85
CLK2 P49760 1/20 0.85
CLK3 P49761 1/20 0.85
GSK3A P49840 1/20 0.85
GSK3B P49841 1/20 0.85
CDK7 P50613 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rg-547 SCHEMBL2397067 0.92 CDK1 (1.00) CDK1CDK4CCND1CDK2CASK
Rg-547 SCHEMBL29644949 0.92 CDK1 (1.00) CDK1CDK4CCND1CDK2CASK
SCHEMBL3522463 0.91 CDK1 (0.89) CDK1CDK4CCND1CDK2CASK
SCHEMBL4350963 0.90 CDK1 (0.79) CDK1CDK4CCND1CDK2CASK
SCHEMBL4350323 0.90 CDK1 (0.79) CDK1CDK4CCND1CDK2CASK
SCHEMBL3522526 0.89 CDK1 (0.91) CDK1CDK4CCND1CDK2CASK
SCHEMBL4357401 0.87 CDK1 (0.74) CDK1CDK4CCND1CDK2CASK
SCHEMBL4354324 0.87 CDK1 (0.74) CDK1CDK4CCND1CDK2CASK
SCHEMBL4359504 0.87 CDK1 (0.74) CDK1CDK4CCND1CDK2CASK
SCHEMBL4352814 0.87 CDK1 (0.82) CDK1CDK4CCND1CDK2CASK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2748331-A1 SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS Lead Discovery Center GmbH (DE) 2014-07-02 EP disclosed
WO-2013026890-A1 SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2013-02-28 WO disclosed